Last reviewed · How we verify

NCT06726733: ICU

Assessing Intensive Care Unit (ICU) Indications: Human vs. ChatGPT-4o Predictions

Completed Last updated 14 April 2026
What this trial tests

trial in Intensive Care Unit (ICU) Admission in 624 participants. Completed in 28 February 2025.

Timeline
1 September 2024
Primary endpoint
30 November 2024
28 February 2025

Quick facts

Lead sponsorBursa Yuksek Ihtisas Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment624
Start date1 September 2024
Primary completion30 November 2024
Estimated completion28 February 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Bursa Yuksek Ihtisas Training and Research Hospital

Who can join

18 and older, any sex, with Intensive Care Unit (ICU) Admission or Emergency Department Patient. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This retrospective study evaluates the accuracy of ICU admission indications by comparing clinical decisions with predictions from ChatGPT-4. Patient data, including demographics, vital signs, laboratory results, imaging findings, and clinical decisions, will be retrospectively collected and documented systematically using Case Report Forms. The model will be trained using ICU admission guidelines and tasked to predict ICU needs based on collected patient data. This study aims to systematically assess the alignment between AI-based predictions and clinical decisions for ICU admissions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Intensive Care Unit (ICU) Admission

Currently open trials in the same condition.

Other Bursa Yuksek Ihtisas Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06726733.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing